Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055729
Filing Date
2021-11-09
Accepted
2021-11-09 16:12:54
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20210930.htm   iXBRL 10-Q 2325902
2 EX-31.1 achv-ex311_6.htm EX-31.1 9068
3 EX-32.1 achv-ex321_7.htm EX-32.1 4891
  Complete submission text file 0001564590-21-055729.txt   7458986

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA achv-20210930.xsd EX-101.SCH 54087
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20210930_cal.xml EX-101.CAL 36772
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20210930_def.xml EX-101.DEF 210441
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20210930_lab.xml EX-101.LAB 391660
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20210930_pre.xml EX-101.PRE 304447
9 EXTRACTED XBRL INSTANCE DOCUMENT achv-10q_20210930_htm.xml XML 1232104
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 211392290
SIC: 2835 In Vitro & In Vivo Diagnostic Substances